Source: FinSMEs

Health Catalyst Capital Management: Holmusk Closes US$21.5M Series A Funding Round

Holmusk, a Singapore-based data science and health technology company, raised US$21.5m in funding. The round was led by Optum Ventures and Health Catalyst Capital with participation from existing investors Heritas Capital and other individuals. In conjunction with the funding, Dr. Vijay Barathan from Optum Ventures (OV) and Charles Boorady from Health Catalyst Capital (HCC) will [...]The post Holmusk Closes US$21.5M Series A Funding Round appeared first on FinSMEs.

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Health Catalyst Capital Management yet.

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more